SG Americas Securities’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-12,980
| Closed | -$50K | – | 2697 |
|
2025
Q1 | $50K | Sell |
12,980
-687
| -5% | -$2.65K | ﹤0.01% | 2858 |
|
2024
Q4 | $84K | Buy |
13,667
+1,378
| +11% | +$8.47K | ﹤0.01% | 2487 |
|
2024
Q3 | $66K | Buy |
+12,289
| New | +$66K | ﹤0.01% | 2818 |
|
2024
Q2 | – | Sell |
-11,316
| Closed | -$46K | – | 2524 |
|
2024
Q1 | $46K | Sell |
11,316
-7,541
| -40% | -$30.7K | ﹤0.01% | 2443 |
|
2023
Q4 | $50K | Sell |
18,857
-1,050
| -5% | -$2.78K | ﹤0.01% | 2645 |
|
2023
Q3 | $47K | Buy |
+19,907
| New | +$47K | ﹤0.01% | 2651 |
|
2023
Q2 | – | Sell |
-15,040
| Closed | -$87K | – | 2165 |
|
2023
Q1 | $87K | Buy |
+15,040
| New | +$87K | ﹤0.01% | 2696 |
|
2022
Q4 | – | Sell |
-9,936
| Closed | -$166K | – | 2768 |
|
2022
Q3 | $166K | Sell |
9,936
-1,876
| -16% | -$31.3K | ﹤0.01% | 2196 |
|
2022
Q2 | $165K | Buy |
+11,812
| New | +$165K | ﹤0.01% | 2548 |
|
2022
Q1 | – | Sell |
-5,639
| Closed | -$121K | – | 2673 |
|
2021
Q4 | $121K | Buy |
+5,639
| New | +$121K | ﹤0.01% | 2671 |
|